Gilead (GILD) +5.4% to $68.40 following its earnings beat yesterday and after Merrill/BofA...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

Gilead (GILD) +5.4% to $68.40 following its earnings beat yesterday and after Merrill/BofA raises the firm's price target to $95/share. That's "a new Street high by a mile," says Notable Calls.